| 中文名 | 5-(2-甲氧基苯氧基)-[2,2'-二嘧啶]-4,6(1H,5H)-二酮 |
|---|---|
| 英文名 | 5-(2-Methoxyphenoxy)-[2,2-Bipyrimidine]-4,6(1H,5H)-Dione |
| 中文别名 |
波生坦二酮
波生坦杂质8 5-(2-甲氧基苯氧基)-[2,2'-二 5-(2-甲氧基苯氧基)-[2,2’-二嘧啶]-4,6(1H,5H)-二酮 波森坦杂质13 5-(2-甲氧基苯氧基)-[2,2'-二嘧啶]-4,6(1H,5H)-二酮(波生坦中间体) 5-(2-甲氧基苯氧基)-[2,2'-二嘧啶]-4,6(1H,5H)-二酮(SM1) |
| 英文别名 |
(RS)-5-(2-methoxy-phenoxy)-1H-bipyrimidine-4,6-dione
Bosentan Impurity 13 Bosenta dione 5-(2-methoxyphenoxy)-[2,2' 5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1h,5h)-dione 5-(2-METHOXYPHENOXY)-2-(PYRIMIDIN-2-YL)PYRIMIDINE-4,6(1H,5H)-DIONE,PURITY: MIN(HPLC) 2,2'-Bipyrimidine]-4,6(1H,5H)-dione, 5-(2-methoxyphenoxy) 5-(2-Methoxyphenxoy)-[2,2'-bipyrimidine]-4 5-(2-Methoxyphenxoy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione 5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidine-4,6(1H,5H)-dione Bosentan interMediate 5- (2-Methoxyphenoxy) - [2,2 '- pyrimidine] -4,6 (1H, 5H) - dione 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione 5-(2-Methoxyphenoxy)-[2,2'-BipyriMidine]-4,6(1H,5H) 5-(2-Methoxyphenoxy)-2-(pyriMidin-2-yl)-1,4,5,6-tetrahydropyriMidine-4,6-dione 5- (2-Methoxyphenoxy) - [2,2 '- Dipyrimidine] -4,6 (1H, 5H) - dione 5-(O-methoxyphenoxy)-2-pymidin-2-yl)-4,6-(1H,5H)-pymidine dione 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione CAS NO.150-4 CAS NO.150-4 5-(2-Methoxyphenoxy)-2,2'-bipyrimidine-4,6(1H,5H)-dione |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 分子式 | C15H12N4O4 |
| 分子量 | 312.280 |
| 精确质量 | 312.085846 |
| PSA | 102.77000 |
| LogP | -0.24 |
| 折射率 | 1.676 |
| 储存条件 | 2-8°C, 干燥 |
| 危害码 (欧洲) | Xi |
|---|---|
| 海关编码 | 2933599090 |
|
~%
150728-12-4 |
| 文献:US2012/136015 A1, ; Page/Page column 6-7 ; |
|
~25%
150728-12-4 |
| 文献:AUSPEX PHARMACEUTICALS, INC. Patent: US2008/242687 A1, 2008 ; Location in patent: Page/Page column 32; 34 ; US 20080242687 A1 |
| 上游产品 4 | |
|---|---|
| 下游产品 1 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |